MYOPIA

A COMMON CONDITION THAT INVOLVES NEARSIGHTEDNESS (DIFFICULTY SEEING FAR). DISTANCE OBJECTS APPEAR BLURRY AND IF NOT ADDRESSED CAN BECOME WORSE AS YOUR CHILD GETS OLDER. COMMON ISSUES OF MYOPIA ARE HIGH MYOPIA AND DEGENERATIVE MYOPIA. YOUR EYEBALL GETS LONGER WHICH CAN INCREASE CHANCES OF HAVING AN ABNORMALLY HIGH PRESCRIPTION. GENETICS PLAY A KEY PART IN MYOPIA FOR KIDS AS WELL AS KIDS SPENDING SIGNIFICANTLY LESS TIME OUTDOORS AND MORE TIME INDOORS ON DIGITAL DEVICES BOTH AT HOME AND IN SCHOOL. THIS INDOOR/OUTDOOR IMBALANCE APPEARS TO BE AN UNCONTROLLABLE VARIABLE AND IS CONTRIBUTING TO A MYOPIA EPIDEMIC WORLDWIDE.

UNTREATED HIGH MYOPIA

WHEN LEFT UNDIAGNOSED AND UNTREATED, IT CAN LEAD TO A HOST OF COMPLICATIONS, SUCH AS REDUCED ABILITY TO LEARN, AND LATER IN LIFE:

·  CATARACTS TEND TO DEVELOP SOONER

·  2 TO 3 TIMES MORE LIKELY TO GET GLAUCOMA.

·  INCREASED RISK OF RETINAL DETACHMENT AND MACULAR DEGENERATION

SIGNS AND SYMPTOMS

YOUR CHILD MAY DISPLAY ONE OR MORE OF THE FOLLOWING HABITS DUE TO MYOPIA:

·  PERSISTENT SQUINTING

·  NEEDING TO SIT CLOSER TO SEE

·  HOLDING BOOKS AND ELECTRONICS VERY CLOSE TO SEE

·  SEEMING TO BE UNAWARE OF DISTANT OBJECTS

·  EXCESSIVE BLINKING

·  RUBBING EYES FREQUENTLY

·  POOR GRADES OR FALLING BEHIND IN SCHOOL

MYOPIA MANAGEMENT PROGRAMS

FORTUNATELY, WE NOW HAVE SEVERAL SAFE AND EFFECTIVE OPTIONS TO HELP US ACCOMPLISH THE GOAL OF MYOPIA MANAGEMENT. MYOPIA MANAGEMENT IS MADE TO SLOW DOWN MYOPIA PROGRESSION BY AT LEAST 50%.

A TREATMENT PLAN WILL BE SET IN PLACE THAT MAY PREVENT FURTHER COMPLICATIONS ASSOCIATED WITH MYOPIA:

ORTHOKERATOLOGY LENSES – GOLD STANDARD OF MYOPIA MANAGEMENT

- THEY ARE CUSTOM MADE GAS–PERMEABLE CONTACT LENSES THAT ARE APPLIED AT BEDTIME AND WORN OVERNIGHT. WHILE SLEEPING, THE LENSES WILL GENTLY RESHAPE THE CURVATURE OF THE CORNEA TO CORRECT THEIR VISION. THE PATIENT REMOVES THE ORTHO-K LENSES EVERY MORNING AND WILL BE ABLE TO SEE WITHOUT DAYTIME GLASSES OR CONTACT LENSES.

MISIGHT 1 DAY SOFT LENSES – FDA APPROVED

- ONLY FDA APPROVED DAILY WEAR, SINGLE-USE SOFT CONTACT LENS

LOW-DOSE ATROPINE DROPS – EYE DROPS AT NIGHT

- INVOLVED IN THE REGULATION OF ELONGATION OF THE EYE. IT IS THE ONLY ‘OFF-LABEL’ MEDICATION THAT HAS DEMONSTRATED TO BE CONSISTENTLY EFFECTIVE IN SLOWING MYOPIA PROGRESSION.

For More Information